Immunotherapy for acute myelogenous leukaemia.
作者信息
Powles R
出版信息
Br J Cancer Suppl. 1973 Aug;1:262-5.
Abstract
摘要
相似文献
1
Immunotherapy for acute myelogenous leukaemia.
Br J Cancer Suppl. 1973 Aug;1:262-5.
2
Active specific immunotherapy for acute myelogenous leukaemia.
Johns Hopkins Med J Suppl. 1974;3:333-40.
3
Advances in the treatment of acute myelogenous leukemia.
N Engl J Med. 1979 May 24;300(21):1189-99. doi: 10.1056/NEJM197905243002105.
4
Immunotherapy of acute myelogenous leukemia in man.
Natl Cancer Inst Monogr. 1973 Dec;39:243-7.
5
[Principles and aims of the treatment of leukaemia (author's transl)].
Wien Klin Wochenschr. 1978 Dec 8;90(23):817-25.
6
Chemotherapy and immunotherapy interspersion: clinical studies in acute myeloblastic leukaemia.
Recent Results Cancer Res. 1977(62):90-4. doi: 10.1007/978-3-642-81174-6_13.
7
Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.
Br J Cancer. 1978 Feb;37(2):282-8. doi: 10.1038/bjc.1978.37.
8
[Use of chemotherapy and immunotherapy in the treatment of patients with acute myeloblastic leukemia (proceedings)].
Minerva Med. 1977 Oct 27;68(51):3528-32.
9
[Chemo-immunotherapy of acute myeloid leukemia with levamisole and 9 cytostatics].
Ugeskr Laeger. 1977 Feb 28;139(9):521-4.
10
Hypoplastic acute myelogenous leukaemia.
Br J Haematol. 1975 Oct;31(2):167-76. doi: 10.1111/j.1365-2141.1975.tb00847.x.
引用本文的文献
1
Overexpression of CD200 is a Stem Cell-Specific Mechanism of Immune Evasion in AML.
J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2021-002968.
2
Failure to detect autologous antibodies in the remission sera of patients with AML: complications introduced by the presence of rheumatoid factor.
Br J Cancer. 1980 Sep;42(3):385-91. doi: 10.1038/bjc.1980.249.
3
Immunotherapy for acute myelogenous leukaemia.
Br J Cancer. 1973 Nov;28(5):365-76. doi: 10.1038/bjc.1973.162.
4
Adult acute leukaemia.
Br J Cancer. 1974 Sep;30(3):272-8. doi: 10.1038/bjc.1974.191.
5
Effects of BCG, Corynebacterium parvum, and methanol-extration residue in the reduction of mortality from Staphylococcus aureus and Candida albicans infections in immunosuppressed mice.
Infect Immun. 1975 Dec;12(6):1325-30. doi: 10.1128/iai.12.6.1325-1330.1975.
6
Colony-forming ability of marrow from patients receiving immunotherapy during chemotherapy-induced remission in acute myeloid leukaemia.
J Clin Pathol. 1977 Jan;30(1):70-5. doi: 10.1136/jcp.30.1.70.
7
8
Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.
Br J Cancer. 1978 Feb;37(2):282-8. doi: 10.1038/bjc.1978.37.
9
Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.
World J Surg. 1977 Sep;1(5):555-83. doi: 10.1007/BF01556181.
本文引用的文献
1
Recognition of leukaemia cells as foreign before and after autoimmunization.
Br Med J. 1971 Feb 27;1(5747):486-9. doi: 10.1136/bmj.1.5747.486.
2
Approaches to the immunological treatment of cancer in man.
Br Med J. 1969 Oct 4;4(5674):7-10. doi: 10.1136/bmj.4.5674.7.
3
4
Management of adult acute myelogenous leukaemia.
Br Med J. 1973 Jan 20;1(5846):131-7. doi: 10.1136/bmj.1.5846.131.
5
Eighty years of immunotherapy: a review of immunological methods used for the treatment of human cancer.
Br J Cancer. 1972 Jun;26(3):141-53. doi: 10.1038/bjc.1972.21.
Zotero 插件